ACADIA Pharmaceuticals Inc Announces Outcome of FDA Advisory Committee for NUPLAZID® Transcript - Thomson StreetEvents

ACADIA Pharmaceuticals Inc Announces Outcome of FDA Advisory Committee for NUPLAZID® Transcript

ACADIA Pharmaceuticals Inc Announces Outcome of FDA Advisory Committee for NUPLAZID® Transcript - Thomson StreetEvents
ACADIA Pharmaceuticals Inc Announces Outcome of FDA Advisory Committee for NUPLAZID® Transcript
Published Jun 17, 2022
Published Jun 17, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ACAD.OQ corporate analyst meeting

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
ACADIA Pharmaceuticals Inc
Ticker
ACAD.OQ
Time
12:45pm GMT
Format:
PDF Adobe Acrobat
Buy Now

ACADIA Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript – 2023-01-10 – US$ 54.00 – Edited Transcript of ACAD.OQ presentation 10-Jan-23 5:00pm GMT

ACADIA Pharmaceuticals Inc Q3 2022 Earnings Call Transcript – 2022-11-02 – US$ 54.00 – Edited Transcript of ACAD.OQ earnings conference call or presentation 2-Nov-22 8:30pm GMT

ACADIA Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript – 2022-09-13 – US$ 54.00 – Edited Transcript of ACAD.OQ presentation 13-Sep-22 3:10pm GMT

ACADIA Pharmaceuticals Inc at Citi BioPharma Conference Transcript – 2022-09-08 – US$ 54.00 – Edited Transcript of ACAD.OQ presentation 8-Sep-22 5:00pm GMT

ACADIA Pharmaceuticals Inc Q2 2022 Earnings Call Transcript – 2022-08-08 – US$ 54.00 – Edited Transcript of ACAD.OQ earnings conference call or presentation 8-Aug-22 8:30pm GMT

ACADIA Pharmaceuticals Inc at Bank of America Healthcare Conference Transcript – 2022-05-10 – US$ 54.00 – Edited Transcript of ACAD.OQ presentation 10-May-22 10:20pm GMT

ACADIA Pharmaceuticals Inc Q1 2022 Earnings Call Transcript – 2022-05-04 – US$ 54.00 – Edited Transcript of ACAD.OQ earnings conference call or presentation 4-May-22 8:30pm GMT

ACADIA Pharmaceuticals Inc at Needham Neuroscience Forum (Virtual) Transcript – 2022-03-16 – US$ 54.00 – Edited Transcript of ACAD.OQ presentation 16-Mar-22 7:20pm GMT

ACADIA Pharmaceuticals Inc at Cowen Health Care Conference (Virtual) Transcript – 2022-03-09 – US$ 54.00 – Edited Transcript of ACAD.OQ presentation 9-Mar-22 7:50pm GMT

ACADIA Pharmaceuticals Inc Q4 2021 Earnings Call Transcript – 2022-02-28 – US$ 54.00 – Edited Transcript of ACAD.OQ earnings conference call or presentation 28-Feb-22 9:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "ACADIA Pharmaceuticals Inc Announces Outcome of FDA Advisory Committee for NUPLAZID® Transcript" Jun 17, 2022. Alacra Store. May 11, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/ACADIA-Pharmaceuticals-Inc-Announces-Outcome-of-FDA-Advisory-Committee-for-NUPLAZID-T15250655>
  
APA:
Thomson StreetEvents. (2022). ACADIA Pharmaceuticals Inc Announces Outcome of FDA Advisory Committee for NUPLAZID® Transcript Jun 17, 2022. New York, NY: Alacra Store. Retrieved May 11, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/ACADIA-Pharmaceuticals-Inc-Announces-Outcome-of-FDA-Advisory-Committee-for-NUPLAZID-T15250655>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.